Recently, Medtronic, a global medical device giant, disclosed in a filing with the U.S. Securities and Exchange Commission that due to strategic adjustments, the company paid severance of over $3 million (approximately RMB 21.46 million) to former Executive Vice President and President of the Medical Surgical Portfolio, Bob White (hereinafter referred to as White). The payment covered two years of salary, target bonuses each amounting to $1.6 million, as well as health and dental benefits totaling $61,259. White's departure was announced in February this year and officially took effect on April 26. Medtronic stated that this change was due to the company’s decision to exit the ventilator business and integrate relevant departments, resulting in the elimination of White’s position.
▲ Bob White
Since Medtronic acquired Covidien in 2015, White has played a key leadership role in integrating operations across the Asia-Pacific region, earning significant recognition for his contributions. At the same time, Medtronic disclosed compensation details of Chairman and CEO Geoff Martha and other senior executives, while also revealing a reduction in the company’s total workforce. In addition to White, two executive vice presidents have stepped down this year: Rob ten Hoedt retired in June, and Karen Parkhill resigned in August to join HP as Chief Financial Officer.
Before joining Medtronic, White held key positions at GE Healthcare and Merge Healthcare. According to Medtronic's severance policy, several senior executives, including Martha, would receive severance pay equivalent to two years of their annual salary plus additional benefits such as outplacement assistance and health insurance coverage for up to 24 months if they were involuntarily terminated without cause. It was reported that White’s compensation ranked second among Medtronic executives.
Severe Polarization in Salary
In the field of medical technology, attracting and retaining top talent is the core competitiveness of enterprises.
According to foreign media reports, in the 2024 fiscal year, the total compensation for Medtronic Chairman and Chief Executive Officer Geoff Martha reached$20.1 millionThis includes a base salary of $1.4 million, $12 million in stock awards, $4.5 million in option awards, and $1.9 million in cash awards through the Medtronic Incentive Plan (MIP). In addition, he enjoys other benefits totaling $305,496, covering $182,870 for personal use of the company aircraft and a $40,000 business allowance (other executives’ business allowances are $24,000). Compared to $15.4 million in fiscal year 2023, Martha’s total compensation increased by 30%.
Former Executive Vice President and Chief Financial Officer Karen Parkhill resigned on August 2, 2024, to take up the position of Chief Financial Officer at HP. Parkhill's total compensation for the 2024 fiscal year was$8 million, specifically including a salary of $911,233, stock awards of $4.4 million, option awards of $1.7 million, MIP cash awards of $943,091, and additional compensation of $66,187. Compared to $6.1 million in fiscal year 2023, Parkhill's total compensation also increased by 30%.
The total 2024 salaries of the remaining executives are as follows:
- Executive Vice President of Global Operations and Supply Chain, Gregory Smith: $7.7 million
- Executive Vice President and President of Cardiovascular, Sean Salmon: $6.6 million
- Executive Vice President and President of Neuroscience Brett Wall: $6.4 million
Medtronic demonstrated solid financial performance in the fiscal year 2024, with operating revenue increasing by 4% year-over-year to $32.4 billion. However, net income and diluted earnings per share slightly declined, dropping by 2% respectively. The company emphasized that its compensation strategy aims to closely align the interests of executives with those of shareholders and employees, ensuring that its compensation plans are not only competitive in the market but also capable of attracting, retaining, and motivating top management talent.
However, at the midpoint of the 2024 fiscal year, Medtronic's median employee compensation slightly decreased by 1%, dropping to $67,769.By contrast, the ratio of the CEO's total compensation to the median employee compensation rose to 296:1, meaning the CEO's pay is nearly 300 times that of an ordinary employee., this gap has widened compared to the previous two years' ratios of 230:1 and 215:1.
Salary reduced,
Positions have also been reduced.
Earlier this year, due to the decline in ventilator sales, the company decided to shut down its ventilator business line, resulting in layoffs at plants in Ireland, Minnesota, and California. In its latest annual report, Medtronic updated its global employee count, announcing that as of February 1, 2024, the total number of employees reached 100,716, a decrease of 1,151 people compared to the same period in 2022, representing a reduction of approximately 1%.
According to incomplete statistics, the layoffs by Medtronic in the past year are as follows:
- In May 2024, Medtronic carried out layoffs in Israel, affecting 35 employees, which accounted for 3% of the company's total workforce in the country. The main department affected was Mazor Robotics, a robotic-assisted surgical equipment company acquired by Medtronic in 2018 for $1.7 billion.
- In April of the same year, 44 employees were laid off at the factory in Carlsbad, California, directly related to Medtronic's plan to divest its respiratory business. The factory belongs to Nellcor Puritan Bennett Corp., a respiratory monitoring and ventilator brand that Medtronic acquired as part of its purchase of Covidien.
- In the past year, Medtronic also implemented early retirement incentive measures, which, while ostensibly for employee welfare, were essentially seen as a form of layoffs.
- In April 2023, Medtronic announced the launch of its layoff plan to employees in its international operations.
Facing the complex changes in the global medical market, Medtronic's strategic adjustments reflect its emphasis on cost control and business focus. Behind the high severance payment is recognition of former executive White and his contributions, while also reflecting the company’s cautious handling of the loss of key talent. In a complex and ever-changing market environment, how Medtronic balances cost control with talent retention, optimizes business layout, and improves employee satisfaction will be critical issues that need continuous attention and resolution in its future development. Medical Device Innovation Network will continue to monitor these developments.▲Source of the article:Medical Device Innovation Network▲Reproduction without permission is prohibited.And can be reprinted after 24 hours.！Disclaimer: This article is intended solely for the purpose of information transmission and is for reference only. It does not constitute any advice on investment or treatment; please evaluate carefully. If it involves issues related to the content, copyright, or other aspects of the work, to protect the rights and interests of both parties, please contact us and we will handle it immediately. If any platform reprints this article, it must take responsibility for the content itself; the Medical Device Innovation Network is not responsible for any secondary dissemination caused by reprints.
